Strategic Planning, Organizational Strategy and Leadership Development

The Food and Drug Administration's (FDA's) mission is to protect the public health by regulating and ensuring the safety of foods, drugs, cosmetics, medical devices and tobacco products. In order for FDA to carry out its mission, its leaders must be trained and empowered to use best-in-class management practices and to collaborate effectively with internal and external stakeholders. Over the last five years CDER and other FDA Centers, including the Office of Regulatory Affairs (ORA) have engaged consultants in support of this and similar initiatives. The consultants have utilized a variety of toolsets to develop documents, plans, training materials, etc. into a comprehensive strategic planning framework. Now that the basic framework has been established, CDER and other FDA centers, wish to expand the scope of the program and add additional services as this initiative moves forward OC.

The scope of this contract includes consulting in the following areas:

 Strategic Planning
 Organizational Development and Change Management
 Executive Coaching and Leadership Development
 Facilitating Knowledge Transfer Among Key Stakeholders
 Program Management Support Necessary to Administer the Contract

 The objective of this contract is to set up a flexible ordering instrument under which FDA Centers can place orders for management consulting services to support continued organizational development and help FDA achieve its mission. FDA anticipates issuing a single award ID/IQ contract with a ceiling of $20M that allows for the issuance of firm-fixed-price and labor-hour type task orders.